BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19223004)

  • 1. Dimethylarsine likely acts as a mouse-pulmonary tumor initiator via the production of dimethylarsine radical and/or its peroxy radical.
    Yamanaka K; Kato K; Mizoi M; An Y; Nakanao M; Hoshino M; Okada S
    Life Sci; 2009 Apr; 84(17-18):627-33. PubMed ID: 19223004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylarsine likely acts as a mouse-pulmonary tumor initiator via the production of dimethylarsine radical and/or its peroxy radical.
    Yamanaka K; Kato K; Mizoi M; An Y; Nakanao M; Hoshino M; Okada S
    Life Sci; 2009 Apr; 84(17-18):627-33. PubMed ID: 26324994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis.
    Yamanaka K; Kato K; Mizoi M; An Y; Takabayashi F; Nakano M; Hoshino M; Okada S
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):385-93. PubMed ID: 15276418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis.
    Yamanaka K; Takabayashi F; Mizoi M; An Y; Hasegawa A; Okada S
    Biochem Biophys Res Commun; 2001 Sep; 287(1):66-70. PubMed ID: 11549254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic-induced bladder cancer in an animal model.
    Cohen SM; Ohnishi T; Arnold LL; Le XC
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):258-63. PubMed ID: 17109909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress.
    Mizoi M; Takabayashi F; Nakano M; An Y; Sagesaka Y; Kato K; Okada S; Yamanaka K
    Toxicol Lett; 2005 Aug; 158(2):87-94. PubMed ID: 16039397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding arsenic carcinogenicity by the use of animal models.
    Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder.
    Kinoshita A; Wanibuchi H; Wei M; Yunoki T; Fukushima S
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):295-305. PubMed ID: 17481689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
    Cruzan G; Bus J; Banton M; Gingell R; Carlson G
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific induction of oxidative stress in terminal bronchiolar Clara cells during dimethylarsenic-induced lung tumor promoting process in mice.
    An Y; Kato K; Nakano M; Otsu H; Okada S; Yamanaka K
    Cancer Lett; 2005 Dec; 230(1):57-64. PubMed ID: 16253761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel metabolic activation associated with glutathione in dimethylmonothioarsinic acid (DMMTA(V))-induced toxicity obtained from in vitro reaction of DMMTA(V) with glutathione.
    Kurosawa H; Shimoda Y; Miura M; Kato K; Yamanaka K; Hata A; Yamano Y; Endo Y; Endo G
    J Trace Elem Med Biol; 2016 Jan; 33():87-94. PubMed ID: 26653748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical.
    Yamanaka K; Hoshino M; Okamoto M; Sawamura R; Hasegawa A; Okada S
    Biochem Biophys Res Commun; 1990 Apr; 168(1):58-64. PubMed ID: 2158319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial metabolite of dimethylarsinic acid is highly toxic and genotoxic.
    Kuroda K; Yoshida K; Yoshimura M; Endo Y; Wanibuchi H; Fukushima S; Endo G
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):345-53. PubMed ID: 15276414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro.
    Nascimento MG; Suzuki S; Wei M; Tiwari A; Arnold LL; Lu X; Le XC; Cohen SM
    Toxicology; 2008 Jul; 249(1):69-74. PubMed ID: 18502017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylarsine and trimethylarsine are potent genotoxins in vitro.
    Andrewes P; Kitchin KT; Wallace K
    Chem Res Toxicol; 2003 Aug; 16(8):994-1003. PubMed ID: 12924927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current progress in animal models of arsenic carcinogenesis].
    An Y
    Wei Sheng Yan Jiu; 2006 Nov; 35(6):814-8. PubMed ID: 17290776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals.
    Yamanaka K; Okada S
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):37-40. PubMed ID: 7843134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concise review of the toxicity and carcinogenicity of dimethylarsinic acid.
    Kenyon EM; Hughes MF
    Toxicology; 2001 Mar; 160(1-3):227-36. PubMed ID: 11246143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active arsenic species produced by GSH-dependent reduction of dimethylarsinic acid cause micronuclei formation in peripheral reticulocytes of mice.
    Kato K; Yamanaka K; Hasegawa A; Okada S
    Mutat Res; 2003 Aug; 539(1-2):55-63. PubMed ID: 12948814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
    Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.